NCT06722391 Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
| NCT ID | NCT06722391 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas, El Paso |
| Condition | Insulin Resistance |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-08-19 |
| Primary Completion | 2029-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-08-19 with a primary completion date of 2029-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=20 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Control and NMES group will self administer stimulation at home. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
Eligibility Criteria
Inclusion Criteria: * Overweight/Obese (BMI ≥25) * Sedentary Lifestyle: Physical Activity Level\<1.4 * Less than 150min/week of structured Exercise Exclusion Criteria: * Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications * Excessive alcohol, drug abuse, smoking * Pregnant Women * Unwilling to adhere to the study Intervention
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06722391 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Insulin Resistance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06722391 currently recruiting?
Yes, NCT06722391 is actively recruiting participants. Contact the research team at sbajpeyi@utep.edu for enrollment information.
Where is the NCT06722391 trial being conducted?
This trial is being conducted at El Paso, United States.
Who is sponsoring the NCT06722391 clinical trial?
NCT06722391 is sponsored by University of Texas, El Paso. The trial plans to enroll 80 participants.